STAND. COM. REP. NO.  1096-20

 

Honolulu, Hawaii

                , 2020

 

RE:   S.B. No. 2917

      S.D. 1

      H.D. 1

 

 

 

 

Honorable Scott K. Saiki

Speaker, House of Representatives

Thirtieth State Legislature

Regular Session of 2020

State of Hawaii

 

Sir:

 

     Your Committee on Health, to which was referred S.B. No. 2917, S.D. 1, entitled:

 

"A BILL FOR AN ACT RELATING TO THE ELECTRONIC PRESCRIPTION ACCOUNTABILITY SYSTEM,"

 

begs leave to report as follows:

 

     The purpose of this measure is to clarify the individuals who may access information stored in the Electronic Prescription Accountability System.

 

     Your Committee received testimony in support of this measure from the Department of Human Services and Department of Public Safety.

 

Your Committee finds that providing authorized Department of Health Med-QUEST Program employees with access to the Electronic Prescription Accountability System, more commonly known as the Prescription Drug Monitoring Program (PDMP), will enhance the Department of Human Services' clinical and program integrity efforts.  Your Committee also finds that allowing licensed health care providers or delegates of the providers employed by the United States Department of Veterans Affairs access to the PDMP will make Hawaii law consistent with federal law, which requires that every state provide these licensed health care providers and their delegates access to their electronic prescription accountability systems, without exception.

 

     Your Committee has amended this measure by:

 

     (1)  Changing the effective date to July 1, 2050, to encourage further discussion; and

 

     (2)  Making technical, nonsubstantive amendments for the purposes of clarity, consistency, and style.

 

     As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 2917, S.D. 1, as amended herein, and recommends that it pass Second Reading in the form attached hereto as S.B. No. 2917, S.D. 1, H.D. 1, and be referred to your Committees on Consumer Protection & Commerce and Judiciary.

 

 

Respectfully submitted on behalf of the members of the Committee on Health,

 

 

 

 

____________________________

JOHN M. MIZUNO, Chair